{"version":"1.0","provider_name":"GBC AG","provider_url":"https:\/\/gbc-investmentresearch.de\/de\/","author_name":"Aleyna Cinar","author_url":"https:\/\/gbc-investmentresearch.de\/de\/author\/aleynac\/","title":"Focus Money - Nebenwerte legen zu - GBC AG","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"vyy0UVidfx\"><a href=\"https:\/\/gbc-investmentresearch.de\/de\/focus-money-nebenwerte-legen-zu\/\">Fo\u00adcus Mo\u00adney \u2013 Ne\u00adben\u00adwer\u00adte le\u00adgen zu<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/gbc-investmentresearch.de\/de\/focus-money-nebenwerte-legen-zu\/embed\/#?secret=vyy0UVidfx\" width=\"600\" height=\"338\" title=\"&#8222;Fo\u00adcus Mo\u00adney \u2013 Ne\u00adben\u00adwer\u00adte le\u00adgen zu&#8220; &#8211; GBC AG\" data-secret=\"vyy0UVidfx\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/gbc-investmentresearch.de\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/gbc-investmentresearch.de\/wp-content\/uploads\/2024\/10\/Unbenannt-1.png","thumbnail_width":270,"thumbnail_height":120,"description":"...\"\u201eM1 Kliniken hat mit den vorl\u00e4ufigen Zahlen f\u00fcr 2025 den profitablen Wachstumskurs eindrucksvoll best\u00e4tigt\u201c, sagt Manuel H\u00f6lzle von GBC. Mit dem Verkauf von Haemato Pharm sch\u00e4rft M1 zudem das Profil als Pure-Play-Anbieter f\u00fcr medizinische \u00c4sthetik, so der Anlageprofi, der seine Position bei Revo Insurance um 100 St\u00fcck mit Limit 26,50 Euro aufstocken will. H\u00f6lzle: \u201eWir erwarten am 14. Mai gute Q1-Zahlen und damit den Ausbruch der Aktie auf ein neues Hoch.\u201c...\"  hier mehr  Quelle: Focus Money, Ausgabe 20 vom 08.05.2026"}